Understanding Orthorexia Nervosa: A Systematic Review of Meta-analytical Findings
Abstract
Orthorexia Nervosa (ON) is an emerging condition marked by an obsessive focus on healthy eating, often resulting in impairments in well-being, daily functioning, and quality of life. Despite growing awareness, ON is not currently recognized in major psychiatric diagnostic systems, complicating its identification and clinical management.
Objective: This umbrella review aims to synthesize evidence from existing meta-analyses on the prevalence and associated factors of ON, while critically assessing the quality of the current literature.
Methods: A comprehensive review of five meta-analyses was conducted, focusing on ON prevalence rates, its psychological correlates, and the quality of the included studies. The review also evaluated heterogeneity in findings and the reliability of assessment tools used across studies.
Results: Prevalence estimates of ON showed wide variability due to differences in populations and assessment instruments. ON was significantly associated with compulsive exercise, eating disorder symptoms, obsessive-compulsive traits, and perfectionism. Newer diagnostic tools reveal a stronger connection between ON and obsessive-compulsive tendencies, while distinguishing it from traditional eating disorders, due to its focus on food purity rather than weight control. Methodological limitations, such as inconsistent assessment tools and variable study designs, limit the conclusiveness of current evidence, rendering most findings suggestive rather than definitive.…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.